Company news
Thalia Therapeutics PLC news in 2018
Thalia Therapeutics PLC's news releases, calls and decks from 2018, newest first.
Nuvec licence extension
December 20, 2018
Nuvec® research update
November 28, 2018
Nuvec resource changes
November 16, 2018
Filing of further Nuvec® patent application
November 15, 2018
Research collaboration update
November 5, 2018
Research collaboration for novel DNA vaccine
October 2, 2018
Grant of options
September 26, 2018
Acceptance of Nuvec® on EUNCL
September 24, 2018
Strategic Review
September 20, 2018
Clinical trials preliminary results
July 9, 2018
Nuvec® Update
June 18, 2018
Filing of Patent
May 9, 2018
Commencement of Sildenafil Clinical Trial
April 18, 2018
Exercise of Warrants and Total Voting Rights
March 9, 2018
Issue of Equity and Director/PDMR Shareholding
February 5, 2018
Award of Grant and Collaboration with MedImmune UK
February 2, 2018
Global Business Accelerator Programme in Japan
January 24, 2018